Scientists say they have broken the cause of the rare blood clots associated with the Oxford / AstraZeneca and Johnson & Johnson coronavirus vaccines and believe the blows can be adapted to make the reaction complete.
Rolf Marschal, a professor at Goethe University in Frankfurt Germany who has been conducting research on the rare state since March, said his research has shown that the problem lies with the adenobirus vectors used by both vaccines to deliver the Sars-Cov-2 protein virus in the body.
Entered into the cell nucleus, some fragments of the granular protein are broken down or fragmented, creating mutant versions that cannot be bound to the cell membrane where significant immunization occurs.
According to Marschal’s theory, floating mutant proteins are secreted by cells into the body, causing blood clots in approximately 100,000 people. In contrast, mRNA-based vaccines, such as jabs developed by BioNTech / Pfizer and Moderna, transmit the genetic material of the vertex to the fluid cell and never enter the nucleus.
A rare blood clotting reaction that disrupted the spread of AstraZeneca and J&J covid vaccines has been reported in 309 of the 33 million people who have been vaccinated with AstraZeneca in the UK and has caused 56 deaths. In response, the use of the AstraZeneca property has been restricted or suspended in more than a dozen countries.
In the U.S., eight of the 7.4 million recipients of the J&J vaccine reported a strange reaction.
J&J began spreading its vaccine in Europe with a warning on its label in April due to concerns after a brief delay. But Marschal believes the correct “solution” is that vaccine developers can change the sequence of the vertex protein so that it does not separate.
J&J had already contacted Marschal’s lab to ask for guidance. The shot spike protein was no longer less likely to “bind” than the spike protein owned by AstraZeneca, and the reaction is less common.
“With the data at hand, we can tell companies how to mutate these sequences by coding them in such a way as to avoid unintentionally mixed spike protein reactions,” says Marschal.
Some scientists have warned that more evidence is needed to prove his claims. Marschal said he presented the findings of his laboratory to the Paul-Ehrlich Institute of the German government and the country’s advisory body for vaccination and vaccination.